Assessment of PD-L1 expression in circulating tumor cells in patients with breast cancer.

e13001Background: Evidence is accumulating that the immune checkpoint blockade targeting the programmed death protein 1 (PD-1)/programmed death ligand 1 (PD-L1) axis has improved progression-free a...